145 related articles for article (PubMed ID: 2182246)
21. [Platelet antiaggregants in the treatment of arterial thrombosis].
Ferlito S
Minerva Cardioangiol; 1991 Oct; 39(10):375-89. PubMed ID: 1803283
[TBL] [Abstract][Full Text] [Related]
22. Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries.
Folts JD; Rowe GG
Thromb Res; 1988 May; 50(4):507-16. PubMed ID: 3413717
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.
Yasuda T; Gold HK; Fallon JT; Leinbach RC; Guerrero JL; Scudder LE; Kanke M; Shealy D; Ross MJ; Collen D; Coller BS
J Clin Invest; 1988 Apr; 81(4):1284-91. PubMed ID: 2832448
[TBL] [Abstract][Full Text] [Related]
24. [Platelet anti-aggregant and anticoagulant therapy in the secondary prevention of coronary disease. Preliminary note].
Caruzzo C; Belli R; Beasci R
Boll Soc Ital Cardiol; 1977; 22(7):1027-35. PubMed ID: 618238
[No Abstract] [Full Text] [Related]
25. Combined inhibitory effects of aspirin and ethanol on adrenaline exacerbation of acute platelet thrombus formation in stenosed canine coronary arteries.
Keller JW; Folts JD
Cardiovasc Res; 1990 Mar; 24(3):191-7. PubMed ID: 2346953
[TBL] [Abstract][Full Text] [Related]
26. Current perspectives in the antiplatelet therapy of thrombotic disorders.
Breddin HK
Semin Thromb Hemost; 1989 Apr; 15(2):144-9. PubMed ID: 2665085
[No Abstract] [Full Text] [Related]
27. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis.
Verro P; Gorelick PB; Nguyen D
Stroke; 2008 Apr; 39(4):1358-63. PubMed ID: 18323511
[TBL] [Abstract][Full Text] [Related]
28. Clopidogrel is more effective than aspirin in preventing coronary artery reocclusion after thrombolysis.
Yao SK; Ober JC; Ferguson JJ; Maffrand JP; Anderson HV; Buja LM; Willerson JT
Trans Assoc Am Physicians; 1993; 106():110-9. PubMed ID: 8036734
[No Abstract] [Full Text] [Related]
29. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
30. Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke.
Lenz T; Wilson A
Clin Pharmacokinet; 2003; 42(10):909-20. PubMed ID: 12885264
[TBL] [Abstract][Full Text] [Related]
31. Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
Weselcouch EO; Humphrey WR; Aiken JW
J Pharmacol Exp Ther; 1987 Jan; 240(1):37-43. PubMed ID: 3543298
[TBL] [Abstract][Full Text] [Related]
32. The effect of combined aspirin and dipyridamole therapy on thrombus formation in an arterial thrombogenic lesion in the dog.
Deen HG; Sundt TM
Stroke; 1982; 13(2):179-84. PubMed ID: 7064188
[TBL] [Abstract][Full Text] [Related]
33. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
Weyrich AS; Skalabrin EJ; Kraiss LW
Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
[TBL] [Abstract][Full Text] [Related]
34. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
Schwartz L; Bourassa MG; Lespérance J; Aldridge HE; Kazim F; Salvatori VA; Henderson M; Bonan R; David PR
N Engl J Med; 1988 Jun; 318(26):1714-9. PubMed ID: 2967433
[TBL] [Abstract][Full Text] [Related]
35. Role of platelet-active drugs in coronary artery disease.
Sherry S
Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
[No Abstract] [Full Text] [Related]
36. Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk.
Halkes PH; Gray LJ; Bath PM; Diener HC; Guiraud-Chaumeil B; Yatsu FM; Algra A
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1218-23. PubMed ID: 18535024
[TBL] [Abstract][Full Text] [Related]
37. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
[TBL] [Abstract][Full Text] [Related]
38. Secondary prevention of myocardial infarction.
Davies JA
Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
[TBL] [Abstract][Full Text] [Related]
39. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet; 2006 May; 367(9523):1665-73. PubMed ID: 16714187
[TBL] [Abstract][Full Text] [Related]
40. Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
Lenz TL; Hilleman DE
Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
